University of Pittsburgh and Tuskegee scientists have developed a novel treatment for lung fibrosis. This treatment is based on peptides to enhance a key signaling pathway in fibrosis development and can be delivered through inhalation, directly targeting the affected organ and providing hope to patients of life-limiting lung fibrosis.
